Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

AnaptysBio, Inc. ANAB

Full chart Compare
Set alert

Price alert · ANAB

All alert types
47.51 USD -0.22 (-0.46%)

At closeNov 4, 2026, 5:03 PM EST

47.51 0.00 0.00%

After hours · Nov 4, 5:03 PM ET

45.82 Day range 49.00
20.18 52-week range 72.36
YTD
+47.00%
1 year
+105.14%

Financial health

Altman Z-Score

2.25 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 1
  • P/E 3
  • P/B 1

Valuation

P/E -70.3×
FY 2016: -49.3×FY 2017: -44.2×FY 2018: -17.0×FY 2019: -3.0×FY 2020: -19.6×FY 2021: -11.0×FY 2022: -4.5×FY 2023: -2.3×FY 2024: -1.7×FY 2025: -70.3×
FY 2016 5y median -4.5× FY 2025
P/S 3.8×
FY 2016: 1.8×FY 2017: 133×FY 2018: 210×FY 2019: 36.6×FY 2020: 5.2×FY 2021: 10.1×FY 2022: 56.6×FY 2023: 22.4×FY 2024: 2.7×FY 2025: 3.8×
FY 2016 5y median 10.1× FY 2025
P/B 24.1×
FY 2016: 0.8×FY 2017: 4.3×FY 2018: 2.2×FY 2019: 0.7×FY 2020: 1.0×FY 2021: 1.8×FY 2022: 2.2×FY 2023: 4.4×FY 2024: 3.5×FY 2025: 24.1×
FY 2016 5y median 3.5× FY 2025
P/FCF 45.8×
FY 2016: -3.3×FY 2017: -67.3×FY 2018: -21.2×FY 2019: -4.2×FY 2020: -26.6×FY 2021: -13.4×FY 2022: -7.9×FY 2023: -3.2×FY 2024: -1.8×FY 2025: 45.8×
FY 2016 5y median -3.2× FY 2025
EV/EBITDA 9.7×
FY 2016: 2.1×FY 2017: -44.9×FY 2018: -15.8×FY 2019: -1.3×FY 2020: -7.3×FY 2021: -2.9×FY 2022: -5.0×FY 2023: -2.4×FY 2024: -5.4×FY 2025: 9.7×
FY 2016 5y median -2.9× FY 2025
EV/Sales 2.9×
FY 2016: -0.5×FY 2017: 126×FY 2018: 189×FY 2019: 15.6×FY 2020: 1.9×FY 2021: 2.5×FY 2022: 51.5×FY 2023: 21.4×FY 2024: 5.4×FY 2025: 2.9×
FY 2016 5y median 5.4× FY 2025
FCF Yield 2.2%
FY 2016: -30.4%FY 2017: -1.5%FY 2018: -4.7%FY 2019: -24.0%FY 2020: -3.8%FY 2021: -7.4%FY 2022: -12.7%FY 2023: -31.6%FY 2024: -54.1%FY 2025: 2.2%
FY 2016 5y median -12.7% FY 2025

Profitability

Gross Margin 99.0%
FY 2016: 7.6%FY 2017: -194.4%FY 2018: -1023.9%FY 2019: -1141.7%FY 2020: -6.7%FY 2021: -55.9%FY 2022: -763.2%FY 2023: -671.0%FY 2024: -79.5%FY 2025: 99.0%
FY 2016 5y median -79.5% FY 2025
Operating Margin 20.4%
FY 2016: -18.1%FY 2017: -287.8%FY 2018: -1334.4%FY 2019: -1342.9%FY 2020: -31.8%FY 2021: -89.9%FY 2022: -1119.4%FY 2023: -958.3%FY 2024: -125.9%FY 2025: 20.4%
FY 2016 5y median -125.9% FY 2025
Net Margin -5.6%
FY 2016: -25.5%FY 2017: -300.7%FY 2018: -1233.1%FY 2019: -1216.7%FY 2020: -26.6%FY 2021: -91.5%FY 2022: -1251.3%FY 2023: -953.7%FY 2024: -159.1%FY 2025: -5.6%
FY 2016 5y median -159.1% FY 2025
ROE -35.6%
FY 2016: -10.8%FY 2017: -9.8%FY 2018: -12.7%FY 2019: -24.0%FY 2020: -5.0%FY 2021: -16.2%FY 2022: -49.1%FY 2023: -185.7%FY 2024: -204.9%FY 2025: -35.6%
FY 2016 5y median -49.1% FY 2025
ROIC 14.6%
FY 2016: -5.4%FY 2017: -8.9%FY 2018: -13.4%FY 2019: -26.3%FY 2020: -6.0%FY 2021: -9.0%FY 2022: -19.7%FY 2023: -39.5%FY 2024: -26.1%FY 2025: 14.6%
FY 2016 5y median -19.7% FY 2025
ROA -3.6%
FY 2016: -6.8%FY 2017: -9.1%FY 2018: -12.1%FY 2019: -22.4%FY 2020: -4.8%FY 2021: -9.0%FY 2022: -21.1%FY 2023: -36.2%FY 2024: -30.0%FY 2025: -3.6%
FY 2016 5y median -21.1% FY 2025

Growth (YoY)

Revenue 157.0%
FY 2016: -5.0%FY 2017: -40.1%FY 2018: -50.0%FY 2019: 60.0%FY 2020: 837.5%FY 2021: -15.8%FY 2022: -83.7%FY 2023: 66.8%FY 2024: 432.0%FY 2025: 157.0%
FY 2016 FY 2025
Operating Income 141.7%
FY 2016: 8.9%FY 2017: -851.4%FY 2018: -131.8%FY 2019: -61.0%FY 2020: 77.8%FY 2021: -137.9%FY 2022: -102.7%FY 2023: -42.8%FY 2024: 30.1%FY 2025: 141.7%
FY 2016 FY 2025
EPS (diluted) 91.0%
FY 2016: 36.1%FY 2017: -560.9%FY 2018: -64.5%FY 2019: -44.0%FY 2020: 79.7%FY 2021: -189.0%FY 2022: -116.6%FY 2023: -33.0%FY 2024: 15.8%FY 2025: 91.0%
FY 2016 FY 2025
Free Cash Flow 114.5%
FY 2016: 8.3%FY 2017: -117.3%FY 2018: -151.3%FY 2019: -41.9%FY 2020: 79.1%FY 2021: -221.1%FY 2022: -56.4%FY 2023: -64.4%FY 2024: -11.6%FY 2025: 114.5%
FY 2016 FY 2025

Financial Health

Current Ratio 9.1×
FY 2016: 10.2×FY 2017: 17.9×FY 2018: 19.9×FY 2019: 12.8×FY 2020: 20.0×FY 2021: 34.4×FY 2022: 17.2×FY 2023: 10.9×FY 2024: 9.5×FY 2025: 9.1×
FY 2016 5y median 10.9× FY 2025
Quick Ratio 9.1×
FY 2016: 10.2×FY 2017: 17.9×FY 2018: 19.9×FY 2019: 12.8×FY 2020: 20.0×FY 2021: 34.4×FY 2022: 17.2×FY 2023: 10.9×FY 2024: 9.5×FY 2025: 9.1×
FY 2016 5y median 10.9× FY 2025
Debt / Equity 0.4×
FY 2016: 0.4×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 5.2×FY 2025: 0.4×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -3.2×
FY 2016: 10.5×FY 2017: 2.4×FY 2018: 1.8×FY 2019: 1.8×FY 2020: 12.9×FY 2021: 8.5×FY 2022: 0.5×FY 2023: 0.1×FY 2024: -2.7×FY 2025: -3.2×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 0.6×
FY 2016: -6.6×FY 2017: -16.2×FY 2018: -40.4×FY 2019: -103×FY 2020: 0.0×FY 2021: -39.2×FY 2022: -5.5×FY 2023: -9.1×FY 2024: -2.3×FY 2025: 0.6×
FY 2016 5y median -5.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31